31 – 40 of 178
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations
- Contribution to journal › Letter
-
Mark
N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL)
- Contribution to journal › Article
-
Mark
Trailblazing precision medicine in Europe : A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany
- Contribution to journal › Article
-
Mark
Application of precision medicine in clinical routine in haematology—Challenges and opportunities
- Contribution to journal › Scientific review
- 2021
-
Mark
Combinatorial molecule screening identifies a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells
- Contribution to journal › Article
-
Mark
Clinical and genomic characterization of patients diagnosed with the provisional entity Acute myeloid leukemia with BCR-ABL1, a Swedish population-based study
- Contribution to journal › Article
-
Mark
Single-cell sequencing in translational cancer research and challenges to meet clinical diagnostic needs
- Contribution to journal › Scientific review
-
Mark
Precisionsmedicin standard vid flera hematologiska sjukdomar
- Contribution to journal › Article
- 2020
-
Mark
A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells
- Contribution to journal › Article
-
Mark
13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking
- Contribution to journal › Article
